Provider
P8-25 Update to Reimbursement Policy: Commercial General Coding 074 Cellular and Gene Therapy Product
Program effective Date: Feb 03, 2025
Documents & Forms Results
Displaying 2781 - 2790 of 3627 results
Provider
2025 February Bulletins
Program effective Date: Feb 03, 2025
Financial Information
Provider
Commercial Reimbursement Policy Intraoperative Neurophysiological Monitoring (IONM)
Provider
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Program effective Date: Oct 10, 2016
Provider
P56-17 Implementation of a Medical Drug Exclusions List
Program effective Date: Oct 16, 2017
Provider
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Jul 05, 2017
Provider
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Program effective Date: Oct 28, 2016
Provider
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Program effective Date: Nov 09, 2016
Provider
P43R1-16 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Nov 01, 2016